Towards the implementation of CYP2D6 and CYP2C19 genotypes in clinical practice: Update and report from a pharmacogenetic service clinic

By Müller Daniel J.   Kekin Ivana   Kao Amy C. C.   Brandl Eva J.  

International Review of Psychiatry, Vol. 25, Iss. 5, 2013-10 ,pp. : 554-571

Informa Healthcare

Access to resources Recommend Favorite

Clinical and molecular diagnosis of cerebrotendinous xanthomatosis with a review of the mutations in the CYP27A1 gene

By Gallus G.   Dotti M.   Federico A.  

Neurological Sciences, Vol. 27, Iss. 2, 2006-06 ,pp. : 143-149

Springer Publishing Company

Access to resources Recommend Favorite

Involvement of CYP3A4 and CYP2D6 in the Metabolism of Haloperidol

By Fang Jian   Baker Glen B.   Silverstone Peter H.   Coutts Ronald T.  

Cellular and Molecular Neurobiology, Vol. 17, Iss. 2, 1997-04 ,pp. : 227-233

Springer Publishing Company

Access to resources Recommend Favorite

Sensory ataxia as a prominent clinical presentation in three families with mutations in CYP7B1

By Fabio Roberto   Marcotulli Christian   Tessa Alessandra   Leonardi Luca   Storti Eugenia   Pierelli Francesco   Santorelli Filippo   Casali Carlo  

Journal of Neurology, Vol. 261, Iss. 4, 2014-04 ,pp. : 747-751

Springer Publishing Company

Access to resources Recommend Favorite

CYP46A1 T/C polymorphism associated with the APOEε4 allele increases the risk of Alzheimer’s disease

By Li Ling   Yin Zegang   Liu Juan   Li Gongbo   Wang Yanjiang   Yan Jiachuan   Zhou Huadong  

Journal of Neurology, Vol. 260, Iss. 7, 2013-07 ,pp. : 1701-1708

Springer Publishing Company

Access to resources Recommend Favorite